Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When will generic fiasap insulin be available?
What's the recommended schedule for lurbinectedin side effect checks?
Norcuron generic name?
How many years does kadcyla's market exclusivity last?
Novartis patent term dabrafenib?

Errin 0.35 mg?

See the DrugPatentWatch profile for Errin

It sounds like you’re looking at a 0.35 mg dose of Errin, but that specific amount isn’t a standard dose for the marketed form of the drug. Errin is a topical 1 % clindamycin phosphate cream used for acne, and the typical usage is a thin layer applied once or twice daily to the affected skin. The amount you apply (in mg) is usually determined by the size of the area, not by a precise milligram dose like 0.35 mg.

If you’re seeing 0.35 mg in a prescription or lab report, it might refer to:

Possibility What it could mean Typical context
Clindamycin oral suspension Doses for oral clindamycin are usually 75–225 mg every 6–8 h in adults; pediatric doses are weight‑based (often 6–12 mg/kg/day divided q6–8 h). 0.35 mg is far below any standard oral dose. Unlikely for a prescription.
Clindamycin IV infusion Adult IV doses are 600 mg q8 h or 900 mg q24 h. 0.35 mg is far too small. Unlikely.
Topical patch or micro‑dose Some investigational patch formulations or skin‑penetration studies might use micro‑doses (e.g., 0.35 mg per application) to test absorption. Possible in a research setting.
Typographical error The intended dose could have been 3.5 mg, 35 mg, or 350 mg, all of which are within a more realistic range for some clindamycin preparations. Likely.

What to do next

  1. Double‑check the prescription or lab printout – verify the drug name, formulation, and dose.
  2. Ask your prescriber or pharmacist – clarify whether 0.35 mg is the correct dose or a mistake.
  3. If this is a research protocol – confirm the intended application method (patch, gel, etc.) and the study’s dosing schedule.

Quick reference for Errin (topical 1 % clindamycin phosphate)

Item Details
Indication Mild to moderate acne (papules, pustules, nodules).
Typical use Apply a thin layer to the affected area once or twice daily.
Duration 4–12 weeks; continue until improvement.
Common side effects Local skin irritation, dryness, pruritus, erythema.
Contraindications Hypersensitivity to clindamycin or any component.
Precautions Avoid contact with eyes; wash hands after application.

If you can share more context (e.g., the full prescription text, the condition you’re treating, or the form you’re using), I can give a more precise explanation.



Other Questions About Errin :

Errin tablet? Does errin have estrogen? Errin discount? Errin cost? Buy errin? Errin pills? What is errin?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

The provided label excerpts only support counseling that Errin does not protect against HIV infection or other sexually transmitted diseases. The AI response includes multiple claims not evaluated against the supplied label excerpts and is therefore not verifiably aligned; at minimum, any opposite claim would be contradicted.

Category Scores

Indication
60
Partial
Indication
60
Partial
Warnings
0
Poor

Accurate Statements

This product is used to prevent pregnancy (contraception).
Supported by label patient counseling excerpt: “This product (like all oral contraceptives) is used to prevent pregnancy.”

Unsupported Statements

Errin is a brand name for progestogen-only birth control pills.
Not supported by the provided label excerpts.
Errin contains 0.35 mg of norethindrone in each pill.
Not supported by the provided label excerpts.
Progestogen-only pills containing 0.35 mg of norethindrone are usually taken every day without a hormone-free break.
Not supported by the provided label excerpts.
This type of progestogen-only pill is sometimes prescribed for certain hormone-related cycle symptoms, depending on local prescribing practices.
Not supported by the provided label excerpts.
Progestogen-only pills are generally taken one pill daily at about the same time each day.
Not supported by the provided label excerpts.
Progestogen-only pills generally have no week off.
Not supported by the provided label excerpts.
Common side effects include irregular bleeding or spotting, headache, breast tenderness, nausea, and mood changes.
Not supported by the provided label excerpts.
Some people experience changes in bleeding patterns over the first few months while using progestogen-only pills.
Not supported by the provided label excerpts.
Missed-dose rules depend on the exact product instructions and how late the missed pill was.
Not supported by the provided label excerpts.
Progestogen-only pills are often preferred for people who cannot take estrogen.
Not supported by the provided label excerpts.
Progestogen-only pills may require clinician review in the presence of active or past blood clots.
Not supported by the provided label excerpts.
Progestogen-only pills may require clinician review in the presence of certain hormone-sensitive cancers.
Not supported by the provided label excerpts.
Progestogen-only pills may require clinician review in the presence of unexplained vaginal bleeding.
Not supported by the provided label excerpts.
Progestogen-only pills may require clinician review in the presence of severe liver disease.
Not supported by the provided label excerpts.
The '0.35 mg' refers to the amount of progestogen in each tablet.
Not supported by the provided label excerpts.
The 0.35 mg strength determines the brand's dosing schedule and the medication's classification as a progestogen-only pill.
Not supported by the provided label excerpts.
Missed-dose rules for progestogen-only pills depend on the exact product instructions and how late the missed pill was.
Not supported by the provided label excerpts.

Contradictions

Low

AI Statement
Protection from HIV/STDs

Label Reference
Label contraindication/counseling excerpt in provided text: “Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.” (Section 5 PRECAUTIONS) and “This product ... does not protect against HIV infection (AIDS) and other sexually transmitted diseases.” (Information for the patient excerpt).

Important Omissions

Errin does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The only explicitly provided label content indicates a counseling warning that Errin does not protect against HIV/STDs. Missing or incorrect statements about this could affect patient risk counseling, but no direct dosing or contraindication inaccuracies were evidenced from the provided excerpts.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
The label excerpts provided include explicit HIV/STD non-protection counseling; the AI response set contains a contradicted claim category (“Protection from HIV/STDs”) and includes many other claims that are not supported by the supplied labeling text.

Suggested Improvement
Only include claims that are supported by the provided FDA label excerpts; specifically, ensure the response includes that Errin does not protect against HIV infection (AIDS) and other sexually transmitted diseases.

Drug Brand Mention Assessment

Branding Score
56
Visibility
63
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

progestogen-only birth control pills

Core Claims
  • “Errin 0.35 mg” most commonly refers to Errin
  • Errin is a brand name for progestogen-only birth control pills
  • The pills contain 0.35 mg of norethindrone (norethisterone)
  • They are usually taken every day without a hormone-free break
  • 0.35 mg is the amount of progestogen in each tablet
Differentiators
Pricing Perception: Not Mentioned